Gąsiorowska Anita
Department of Gastroenterology, Medical University of Lodz, Lodz, Poland.
Prz Gastroenterol. 2017;12(4):244-249. doi: 10.5114/pg.2017.72097. Epub 2017 Dec 14.
Gastroesophageal reflux disease (GERD) is a condition in which gastroduodenal contents pass into the oesophagus and cause troublesome symptoms and complications. The aetiopathogenesis of gastroesophageal reflux disease is complex and multifactorial. Acid reflux plays an important role in the GERD pathogenesis, both in erosive and non-erosive reflux disease. Reduction of GERD symptoms and mucosal healing correlates with the number of hours that intragastric acid is suppressed to a pH > 4.0. Mucosal healing was achieved in most of patients who received different types of proton pump inhibitors, but only in 50% of those who received H2 blockers. These findings seem to be best accounted for by differences in the duration and degree of acid suppression achieved by different classes of drugs and perhaps between agents within those classes.
胃食管反流病(GERD)是一种胃十二指肠内容物进入食管并引起不适症状和并发症的疾病。胃食管反流病的病因发病机制复杂且多因素。酸反流在GERD发病机制中起重要作用,无论是在糜烂性还是非糜烂性反流病中。GERD症状的减轻和黏膜愈合与胃内酸被抑制至pH>4.0的小时数相关。大多数接受不同类型质子泵抑制剂的患者实现了黏膜愈合,但接受H2阻滞剂的患者中只有50%实现了黏膜愈合。这些发现似乎最好用不同类别药物实现的抑酸持续时间和程度的差异来解释,也许还可以用这些类别内不同药物之间的差异来解释。